Goldman Sachs Group Inc Vericel Corp Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Vericel Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 327,153 shares of VCEL stock, worth $13.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
327,153
Previous 201,204 62.6%
Holding current value
$13.5 Million
Previous $8.5 Million 111.33%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$40.05 - $59.11 $5.04 Million - $7.44 Million
125,949 Added 62.6%
327,153 $18 Million
Q3 2024

Nov 14, 2024
BUY
$42.25 - $53.56 $2.02 Million - $2.56 Million
47,742 Added 31.11%
201,204 $8.5 Million
Q2 2024

Aug 13, 2024
SELL
$41.71 - $52.9 $1.71 Million - $2.16 Million
-40,895 Reduced 21.04%
153,462 $7.04 Million
Q1 2024

May 15, 2024
SELL
$32.52 - $52.33 $9.04 Million - $14.5 Million
-277,838 Reduced 58.84%
194,357 $10.1 Million
Q4 2023

Feb 13, 2024
SELL
$30.85 - $37.09 $332,532 - $399,793
-10,779 Reduced 2.23%
472,195 $16.8 Million
Q3 2023

May 14, 2024
BUY
$31.69 - $39.25 $341,586 - $423,075
10,779 Added 2.28%
482,974 $16.2 Million
Q3 2023

Nov 14, 2023
BUY
$31.69 - $39.25 $6.9 Million - $8.55 Million
217,731 Added 82.09%
482,974 $16.2 Million
Q2 2023

May 14, 2024
SELL
$29.0 - $38.37 $336,690 - $445,475
-11,610 Reduced 4.19%
265,243 $9.97 Million
Q2 2023

Aug 14, 2023
SELL
$29.0 - $38.37 $336,690 - $445,475
-11,610 Reduced 4.19%
265,243 $9.97 Million
Q1 2023

May 14, 2024
BUY
$23.85 - $31.34 $2.08 Million - $2.73 Million
87,099 Added 45.9%
276,853 $8.12 Million
Q1 2023

May 11, 2023
BUY
$23.85 - $31.34 $2.08 Million - $2.73 Million
87,099 Added 45.9%
276,853 $8.12 Million
Q4 2022

May 14, 2024
SELL
$17.65 - $27.37 $468,007 - $725,742
-26,516 Reduced 12.26%
189,754 $5 Million
Q4 2022

Feb 13, 2023
SELL
$17.65 - $27.37 $468,007 - $725,742
-26,516 Reduced 12.26%
189,754 $5 Million
Q3 2022

May 14, 2024
SELL
$22.62 - $32.54 $126,626 - $182,158
-5,598 Reduced 2.52%
216,270 $5.02 Million
Q3 2022

Nov 10, 2022
SELL
$22.62 - $32.54 $126,626 - $182,158
-5,598 Reduced 2.52%
216,270 $5.02 Million
Q2 2022

May 14, 2024
SELL
$22.88 - $39.45 $5.73 Million - $9.88 Million
-250,327 Reduced 53.01%
221,868 $5.59 Million
Q2 2022

Aug 15, 2022
BUY
$22.88 - $39.45 $402,527 - $694,043
17,593 Added 8.61%
221,868 $5.59 Million
Q1 2022

May 16, 2022
BUY
$31.69 - $43.29 $358,350 - $489,523
11,308 Added 5.86%
204,275 $7.81 Million
Q4 2021

Feb 14, 2022
SELL
$35.2 - $52.6 $2.3 Million - $3.44 Million
-65,418 Reduced 25.32%
192,967 $7.58 Million
Q3 2021

Nov 10, 2021
BUY
$46.35 - $59.75 $12 Million - $15.4 Million
258,385 New
258,385 $12.6 Million

Others Institutions Holding VCEL

# of Institutions
290
Shares Held
49.5M
Call Options Held
98.2K
Put Options Held
135K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $1.95B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email